Cineplex Stock Could Surge Once the 4th Wave Peaks

Cineplex (TSX:CGX) stock is still being plagued by the COVID-19 pandemic, but as restrictions ease, could the stock be slated to soar?

| More on:

Cineplex (TSX:CGX) stock has suffered quite a massive fall from grace. It’s been painful for those investors who held on all the way down, and while it’s tempting to throw in the towel after one of the worst years in the record books, I think it may actually be a great time to put on your contrarian hat.

It’s a long way up. With shares of the Canadian movie theatre and entertainment kingpin now off over 77% from its 2017 all-time high, a time I urged investors to sell, it seems like the battered and bruised stock will never recover to see the mid-$50 levels again, at least without a reverse split.

An aggressive reopening play on the TSX — and volatile as ever

The COVID-19 pandemic remains as uncertain as ever, with the horrific Delta variant causing outbreaks across the globe. And with Lambda and other variants of interest that could grow to become variants of concern, betting on the most aggressive of reopening plays like Cineplex still comes with a high magnitude of risk that’s far higher than most investors can handle.

There’s no shame in walking away from a soured investment if you can’t handle the volatility. Heck, Warren Buffett did so with airline stocks earlier last year. But for those with a diversified portfolio who can handle extreme levels of volatility (think double-digit moves as the “new normal”), I think it makes a tonne of sense to do some buying as Cineplex looks to start climbing off rock bottom.

The road ahead will not be easy, especially if more lockdowns loom. Although people are starting to shrug off the pandemic because they’ve been vaccinated, I do think it’s unwise to think that the pandemic isn’t capable of taking a drastic turn for the worst and that Cineplex is in the clear.

The road ahead hasn’t looked this bright in nearly two years

Things have slowly returned to semi-normal over these past few weeks as Canada wound down from its horrific third wave of COVID-19. Vaccination rates are rising by the day and the nation finds itself in an enviable spot as far as vaccination rates are concerned. Indeed, Canadians feel safer as they head back to activities that they used to enjoy before the pandemic. Many people have enjoyed games at the local Rec Room and films at the local Cineplex for the first time in a while. It’s the first taste of normalcy in over a year and a half. And this taste won’t go away anytime soon.

Moving forward, Cineplex has a path to much higher levels. But that doesn’t mean there won’t be another potentially disastrous pullback en route to higher highs. New films, including must-watch blockbuster hits like James Bond’s No Time to Die will draw in huge crowds if localities keep their doors open in what could be an imminent fourth wave of COVID-19.

Regardless of what happens next, there’s value for long-term investors to be had in Cineplex at these depths.

The recent movie slate has been quite modest, and straight-to-stream hits like Black Widow may have seen their box office numbers cannibalized by options to stream the film. In the era of COVID-19, muted box office results and sub-par movie slates are to be expected. But over the extremely long term, once the COVID-19 threat has faded,  Cineplex could benefit from pent-up demand for its very social form of entertainment, which, I believe, is irreplaceable.

So, if you’re committing to hold shares through volatility over the next three years, I think Cineplex stock is a buy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. The Motley Fool recommends CINEPLEX INC.

More on Investing

profit rises over time
Dividend Stocks

A Dividend Giant I’d Buy Over TD Stock Right Now

TD stock has long been one of the top dividend stocks for investors to consider, but that's simply no longer…

Read more »

ways to boost income
Energy Stocks

Act Fast: These 2 Canadian Energy Stocks Are Must-Buys Before Year-End

Here are two high-potential Canadian energy stocks with stable dividends you can consider adding to your portfolio before the year…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Investing

Should You Buy the Post-Earnings Dip in Dollarama Stock?

Following positive Q3 numbers and future growth prospects, should investors accumulate stock in this popular retailer on the pullback to…

Read more »

analyze data
Dividend Stocks

Top Financial Sector Stocks for Canadian Investors in 2025

From undervalued to powerfully bullish, quite a few financial stocks might be promising prospects for the coming year.

Read more »

Canada national flag waving in wind on clear day
Dividend Stocks

3 TFSA Red Flags Every Canadian Investor Should Know

Day trading in a TFSA is a red flag. Hold index funds like the Vanguard S&P 500 Index Fund (TSX:VFV)…

Read more »

sale discount best price
Stocks for Beginners

Have $2,000? These 2 Stocks Could Be Bargain Buys for 2025 and Beyond

Fairfax Financial Holdings (TSX:FFH) and another bargain buy are fit for new Canadian investors.

Read more »

Rocket lift off through the clouds
Stocks for Beginners

2 Canadian Growth Stocks Set to Skyrocket in the Next 12 Months

Despite delivering disappointing performance in 2024, these two cheap Canadian growth stocks could offer massive upside in 2025.

Read more »

Beware of bad investing advice.
Bank Stocks

Shocking Declines: Canadian Stocks That Disappointed Investors in 2024

TD Bank and Telus International are two TSX stocks that are trading below 52-week highs in December 2024.

Read more »